ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,440Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 2035

$689K Total Retail Price of All Prescriptions

Rank: 143 out of 2035

248 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 248 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 248 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 12,302 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
FUROSEMIDE 582 539 1 7
LISINOPRIL 572 513 2 3
LEVOTHYROXINE SODIUM 566 554 3 4
SIMVASTATIN 510 479 4 1
HYDROCODONE-ACETAMINOPHEN 409 392 S3 5 2
SPIRONOLACTONE 331 314 6 65
MIRTAZAPINE 299 299 7 46
DONEPEZIL HCL 275 272 8 24
AMLODIPINE BESYLATE 261 228 9 6
TRAMADOL HCL 257 240 10 19
METOPROLOL TARTRATE 238 224 11 8
NAMENDA 232 232 12 37
CLOPIDOGREL 231 212 13 30
WARFARIN SODIUM 230 181 14 11
NOVOLIN 70-30 191 172 15 178
ATORVASTATIN CALCIUM 188 173 16 13
GABAPENTIN 181 158 17 14
QUETIAPINE FUMARATE 180 149 18 70
ESCITALOPRAM OXALATE 171 155 19 77
CITALOPRAM HBR 159 149 20 20
FORTICAL 154 147 21 286
LEVOFLOXACIN 145 132 22 99
RANITIDINE HCL 139 136 23 28
PLAVIX 136 117 24 49
RISPERIDONE 134 128 25 68
GENTAMICIN SULFATE 134 129 25 335
OMEPRAZOLE 129 127 27 5
ALLOPURINOL 126 116 28 34
SEROQUEL 124 122 29 153
MEGESTROL ACETATE 122 116 R 30 175
DIVALPROEX SODIUM 117 90 31 75
CARBIDOPA-LEVODOPA 111 102 32 94
FENOFIBRATE 111 95 32 82
CEPHALEXIN 107 104 34 91
ISOSORBIDE MONONITRATE ER 104 101 35 32
FAMOTIDINE 103 98 36 71
GLIPIZIDE 102 69 37 54
LACTULOSE 94 83 38 96
NOVOLIN R 94 87 38 210
HYDRALAZINE HCL 92 70 40 45
TRAZODONE HCL 92 90 40 50
TAMSULOSIN HCL 92 70 40 25
SERTRALINE HCL 90 87 43 23
PRAVASTATIN SODIUM 86 86 44 17
CLONIDINE HCL 81 72 45 61
CARVEDILOL 79 76 46 22
FENTANYL 78 78 S2 47 53
OLANZAPINE 77 66 48 121
LANTUS 73 73 49 40
PANTOPRAZOLE SODIUM 73 65 49 42
LIDODERM 71 67 51 72
ENULOSE 68 68 52 230
HYDROXYZINE HCL 68 51 R 52 208
ATENOLOL 67 67 54 10
ALBUTEROL SULFATE 65 65 55 90
SANTYL 65 55 55 192
OXYCODONE HCL-ACETAMINOPHEN 62 62 S2 57 127
TRICOR 62 52 57 120
POTASSIUM CHLORIDE 61 61 59 18
CLOZAPINE 60 20 60 200
BUSPIRONE HCL 59 47 61 176
IPRATROPIUM BROMIDE 59 59 61 148
CYMBALTA 58 56 63 59
PAROXETINE HCL 58 47 63 69
ZETIA 58 36 63 84
OXYBUTYNIN CHLORIDE 57 51 66 102
PERMETHRIN 56 50 67 455
POLYETHYLENE GLYCOL 3350 54 53 68 48
AMIODARONE HCL 52 52 69 171
TRIAMCINOLONE ACETONIDE 50 44 70 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.